The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice.

MLA

Hu, Longbo, et al. “The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice.” Viruses, vol. 14, no. 5, Apr. 2022. EBSCOhost, https://doi.org/10.3390/v14050854.

APA

Hu, L., Xu, Y., Wu, L., Feng, J., Zhang, L., Tang, Y., Zhao, X., Mai, R., Chen, L., Mei, L., Tan, Y., Du, Y., Zhen, Y., Su, W., & Peng, T. (2022). The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice. Viruses, 14(5). https://doi.org/10.3390/v14050854

Chicago

Hu, Longbo, Yuhua Xu, Liping Wu, Jin Feng, Lu Zhang, Yongjie Tang, Xiang Zhao, et al. 2022. “The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice.” Viruses 14 (5). doi:10.3390/v14050854.